| |
Article Title |
Author(s) |
Pages |
|
|
|
Cover
|
|
OFC
|
|
|
|
How Can We Improve Life Expectancy and Quality of Life in Long-Term Survivors After Allogeneic Stem Cell Transplantation?
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides curative therapy for a variety of diseases. Over the past several decades, significant advances have been made in the field of a...
|
Bipin N. Savani
|
1-3
|
|
|
|
Second Solid Tumors: Screening and Management Guidelines in Long-Term Survivors After Allogeneic Stem Cell Transplantation
With greater numbers of patients surviving long-term after allogeneic stem cell transplantation (SCT), second malignancies have increasingly been recognized. Secondary solid tumors, the most prevalent...
|
Gerard Socié,
J. Douglas Rizzo
|
4-9
|
|
|
|
Challenges to Preventing Infectious Complications, Decreasing Re-hospitalizations, and Reducing Cost Burden in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation
Even though the overall outcome after allogeneic transplant has improved significantly in the last decades, late infectious diseases are still the most important causes of late morbidity and mortality...
|
Shigeo Fuji,
Markus Kapp,
Hermann Einsele
|
10-14
|
|
|
|
Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation: Diagnosis, Monitoring, Prevention, and Treatment
Bronchiolitis obliterans syndrome (BOS) is a life-threatening complication that occurs among recipients of allogeneic lung and hematopoietic stem cell transplantation (allo-HSCT). BOS usually occurs w...
|
Andrea Bacigalupo,
Jason Chien,
Giovanni Barisione,
Steven Pavletic
|
15-24
|
|
|
|
Cardiovascular Complications in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation
Cardiovascular diseases (CVD) are emerging late effects after allogeneic hematopoietic stem cell transplantation (allo-HSCT), leading to considerable morbidity and mortality. These late CVD are in mos...
|
Alicia Rovó,
André Tichelli,
Late Effects Working Party of the European Group for Blood and Marrow Transplantation
|
25-34
|
|
|
|
Management of High Ferritin in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Management of high serum ferritin levels after allogeneic hematopoietic stem cell transplantation (allo-HSCT) should, from the diagnostic standpoint, be based on the pathophysiological mechanisms unde...
|
Eolia Brissot,
Bipin N. Savani,
Mohamad Mohty
|
35-42
|
|
|
|
Gastrointestinal, Hepatobiliary, Pancreatic, and Iron-Related Diseases in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation
Gastrointestinal and hepatobiliary problems in the second year after allogeneic hematopoietic cell transplant (HCT) are usually a continuation of symptoms of protracted acute graft-versus-host disease...
|
Aiko Kida,
George B. McDonald
|
43-58
|
|
|
|
Bone Loss and Avascular Necrosis of Bone After Hematopoietic Cell Transplantation
Advances in transplantation technology and supportive care measures have resulted in significant decrease in early mortality resulting in continued growth in the number of long-term hematopoietic cell...
|
Brian McClune,
Navneet S. Majhail,
Mary E.D. Flowers
|
59-65
|
|
|
|
Endocrine Complications in Long-Term Survivors After Allogeneic Stem Cell Transplant
As survival rates continue to increase after allogeneic stem cell transplant (allo-SCT), the associated long-term complications of transplant need to be taken into consideration. Here, we review the e...
|
Uma Gunasekaran,
Neena Agarwal,
Madan H. Jagasia,
Shubhada M. Jagasia
|
66-72
|
|
|
|
Chronic Kidney Diseases in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation: Monitoring and Management Guidelines
Chronic kidney disease (CKD) occurs commonly (prevalence of approximately 20% in a large series) after allogeneic hematopoietic stem cell transplantation (HSCT). There are three distinct clinical enti...
|
Imad Abboud,
Marie-Noëlle Peraldi,
Sangeeta Hingorani
|
73-82
|
|
|
|
Female Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation: Evaluation and Management
Female long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) incur a significant burden of late effects. Genital graft-versus-host disease (GVHD), human papillomavirus ...
|
Dana Shanis,
Melissa Merideth,
Tajana Klepac Pulanic,
Bipin N. Savani,
Minoo Battiwalla,
Pamela Stratton
et al.
|
83-93
|
|
|
|
Long-Term Follow-up and Management Guidelines in Pediatric Patients After Allogenic Hematopoietic Stem Cell Transplantation
Over the past 50 years there has been considerable progress and success in the field of allogeneic hematopoietic stem cell transplant (HSCT) in children. In addition there has been significant improve...
|
Haydar Frangoul,
Jennifer Najjar,
Jill Simmons,
Jennifer Domm
|
94-103
|
|
|
|
Quality of Life, Social Challenges, and Psychosocial Support for Long-Term Survivors After Allogeneic Hematopoietic Stem-Cell Transplantation
Over the last two decades quality of life (QoL) and the social challenges of allogeneic hematopoietic stem cell transplant (allo-HSCT) survivors have been emerging as subjects of extensive research an...
|
Maxim Norkin,
Jack W. Hsu,
John R. Wingard
|
104-109
|
|
| Frontmatter |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Masthead
|
|
A1
|
|
|
|
Table of Contents
|
|
A2-A3
|
|
|
|
Previous Issues
|
|
A4
|
|
|
|
Future Issues and Recent Issues
|
|
A6
|
|
